BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24464947)

  • 1. Prognostic factors that increase the risk for reduced white matter volumes and deficits in attention and learning for survivors of childhood cancers.
    Reddick WE; Taghipour DJ; Glass JO; Ashford J; Xiong X; Wu S; Bonner M; Khan RB; Conklin HM
    Pediatr Blood Cancer; 2014 Jun; 61(6):1074-9. PubMed ID: 24464947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia.
    Reddick WE; Shan ZY; Glass JO; Helton S; Xiong X; Wu S; Bonner MJ; Howard SC; Christensen R; Khan RB; Pui CH; Mulhern RK
    Cancer; 2006 Feb; 106(4):941-9. PubMed ID: 16411228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling children's white matter volume intelligence and academic achievement in response to CNS-directed therapy.
    Annett RD; Annett GE
    Pediatr Blood Cancer; 2014 Jun; 61(6):960-1. PubMed ID: 24623681
    [No Abstract]   [Full Text] [Related]  

  • 4. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS prophylaxis of childhood leukemia: what are the long-term neurological, neuropsychological, and behavioral effects?
    Stehbens JA; Kaleita TA; Noll RB; MacLean WE; O'Brien RT; Waskerwitz MJ; Hammond GD
    Neuropsychol Rev; 1991 Jun; 2(2):147-77. PubMed ID: 1844707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired brain metabolism and neurocognitive function in childhood leukemia survivors despite complete hormone supplementation in adulthood.
    Follin C; Erfurth EM; Johansson A; Lätt J; Sundgren PC; Österberg K; Spulber G; Mannfolk P; Björkman-Burtscher IM
    Psychoneuroendocrinology; 2016 Nov; 73():157-165. PubMed ID: 27498291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.
    Harila MJ; Winqvist S; Lanning M; Bloigu R; Harila-Saari AH
    Pediatr Blood Cancer; 2009 Aug; 53(2):156-61. PubMed ID: 19405135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
    Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
    J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory.
    Langer T; Martus P; Ottensmeier H; Hertzberg H; Beck JD; Meier W
    Med Pediatr Oncol; 2002 May; 38(5):320-8. PubMed ID: 11979456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological sequelae of central nervous system prophylaxis in survivors of childhood acute lymphoblastic leukemia.
    Said JA; Waters BG; Cousens P; Stevens MM
    J Consult Clin Psychol; 1989 Apr; 57(2):251-6. PubMed ID: 2708613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain Activity Associated With Attention Deficits Following Chemotherapy for Childhood Acute Lymphoblastic Leukemia.
    Fellah S; Cheung YT; Scoggins MA; Zou P; Sabin ND; Pui CH; Robison LL; Hudson MM; Ogg RJ; Krull KR
    J Natl Cancer Inst; 2019 Feb; 111(2):201-209. PubMed ID: 29790971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer.
    Mulhern RK; Khan RB; Kaplan S; Helton S; Christensen R; Bonner M; Brown R; Xiong X; Wu S; Gururangan S; Reddick WE
    J Clin Oncol; 2004 Dec; 22(23):4795-803. PubMed ID: 15570081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intellectual, neuropsychological, and academic functioning in long-term survivors of leukemia.
    Raymond-Speden E; Tripp G; Lawrence B; Holdaway D
    J Pediatr Psychol; 2000 Mar; 25(2):59-68. PubMed ID: 10820944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia.
    Kähkönen M; Metsähonkala L; Minn H; Utriainen T; Korhonen T; Norvasuo-Heilä MK; Harila-Saari A; Aärimaa T; Suhonen-Polvi H; Ruotsalainen U; Solin O; Salmi TT
    Cancer; 2000 Feb; 88(3):693-700. PubMed ID: 10649265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slower processing speed after treatment for pediatric brain tumor and acute lymphoblastic leukemia.
    Kahalley LS; Conklin HM; Tyc VL; Hudson MM; Wilson SJ; Wu S; Xiong X; Hinds PS
    Psychooncology; 2013 Sep; 22(9):1979-86. PubMed ID: 23447439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
    J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological impact of treatment of brain tumors.
    De Luca CR; Conroy R; McCarthy MC; Anderson VA; Ashley DM
    Cancer Treat Res; 2009; 150():277-96. PubMed ID: 19834674
    [No Abstract]   [Full Text] [Related]  

  • 18. Late neurocognitive sequelae in survivors of brain tumours in childhood.
    Mulhern RK; Merchant TE; Gajjar A; Reddick WE; Kun LE
    Lancet Oncol; 2004 Jul; 5(7):399-408. PubMed ID: 15231246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia.
    Cole PD; Kamen BA
    Ment Retard Dev Disabil Res Rev; 2006; 12(3):174-83. PubMed ID: 17061283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Persistent Leukoencephalopathy on Brain White Matter Microstructure in Long-Term Survivors of Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.
    Sabin ND; Cheung YT; Reddick WE; Bhojwani D; Liu W; Glass JO; Brinkman TM; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    AJNR Am J Neuroradiol; 2018 Oct; 39(10):1919-1925. PubMed ID: 30213807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.